OBJECTIVE: Pulmonary arteriovenous malformations caused by abnormal hepatic flow distribution can develop in patients with a single ventricle with an interrupted inferior vena cava. However, preoperatively determining the hepatic baffle design that optimizes hepatic flow distribution is far from trivial. The current study combines virtual surgery and numeric simulations to identify potential surgical strategies for patients with an interrupted inferior vena cava. METHODS: Five patients with an interrupted inferior vena cava and severe pulmonary arteriovenous malformations were enrolled. Their in vivo anatomies were reconstructed from magnetic resonance imaging (n = 4) and computed tomography (n = 1), and alternate virtual surgery options (intracardiac/extracardiac, Y-grafts, hepato-to-azygous shunts, and azygous-to-hepatic shunts) were generated for each. Hepatic flow distribution was assessed for all options using a fully validated computational flow solver. RESULTS: For patients with a single superior vena cava (n = 3), intracardiac/extracardiac connections proved dangerous, because even a small left or right offset led to a highly preferential hepatic flow distribution to the associated lung. The best results were obtained with either a Y-graft spanning the Kawashima to split the flow or hepato-to-azygous shunts to promote mixing. For patients with bilateral superior vena cavae (n = 2), results depended on the balance between the left and right superior inflows. When those were equal, connecting the hepatic baffle between the superior vena cavae performed well, but other options should be pursued otherwise. CONCLUSIONS: This study demonstrates how virtual surgery environments can benefit the clinical community, especially for patients with a single ventricle with an interrupted inferior vena cava. Furthermore, the sensitivity of the optimal baffle design to the superior inflows underscores the need to characterize both preoperative anatomy and flows to identify the best option.
OBJECTIVE:Pulmonary arteriovenous malformations caused by abnormal hepatic flow distribution can develop in patients with a single ventricle with an interrupted inferior vena cava. However, preoperatively determining the hepatic baffle design that optimizes hepatic flow distribution is far from trivial. The current study combines virtual surgery and numeric simulations to identify potential surgical strategies for patients with an interrupted inferior vena cava. METHODS: Five patients with an interrupted inferior vena cava and severe pulmonary arteriovenous malformations were enrolled. Their in vivo anatomies were reconstructed from magnetic resonance imaging (n = 4) and computed tomography (n = 1), and alternate virtual surgery options (intracardiac/extracardiac, Y-grafts, hepato-to-azygous shunts, and azygous-to-hepatic shunts) were generated for each. Hepatic flow distribution was assessed for all options using a fully validated computational flow solver. RESULTS: For patients with a single superior vena cava (n = 3), intracardiac/extracardiac connections proved dangerous, because even a small left or right offset led to a highly preferential hepatic flow distribution to the associated lung. The best results were obtained with either a Y-graft spanning the Kawashima to split the flow or hepato-to-azygous shunts to promote mixing. For patients with bilateral superior vena cavae (n = 2), results depended on the balance between the left and right superior inflows. When those were equal, connecting the hepatic baffle between the superior vena cavae performed well, but other options should be pursued otherwise. CONCLUSIONS: This study demonstrates how virtual surgery environments can benefit the clinical community, especially for patients with a single ventricle with an interrupted inferior vena cava. Furthermore, the sensitivity of the optimal baffle design to the superior inflows underscores the need to characterize both preoperative anatomy and flows to identify the best option.
Authors: David H Frakes; Christopher P Conrad; Timothy M Healy; Joseph W Monaco; Mark Fogel; Shiva Sharma; Mark J T Smith; Ajit P Yoganathan Journal: IEEE Trans Biomed Eng Date: 2003-02 Impact factor: 4.538
Authors: Nancy A Pike; Luca A Vricella; Jeffrey A Feinstein; Michael D Black; Bruce A Reitz Journal: Ann Thorac Surg Date: 2004-08 Impact factor: 4.330
Authors: Kartik S Sundareswaran; Diane de Zélicourt; Shiva Sharma; Kirk R Kanter; Thomas L Spray; Jarek Rossignac; Fotis Sotiropoulos; Mark A Fogel; Ajit P Yoganathan Journal: JACC Cardiovasc Imaging Date: 2009-08
Authors: Christopher M Haggerty; Diane A de Zélicourt; Maria Restrepo; Jarek Rossignac; Thomas L Spray; Kirk R Kanter; Mark A Fogel; Ajit P Yoganathan Journal: Ann Biomed Eng Date: 2012-07-10 Impact factor: 3.934
Authors: Theodorus M J van Bakel; Kevin D Lau; Jennifer Hirsch-Romano; Santi Trimarchi; Adam L Dorfman; C Alberto Figueroa Journal: J Cardiovasc Transl Res Date: 2018-01-08 Impact factor: 4.132
Authors: Maria Restrepo; Mark Luffel; Jake Sebring; Kirk Kanter; Pedro Del Nido; Alessandro Veneziani; Jarek Rossignac; Ajit Yoganathan Journal: Ann Biomed Eng Date: 2014-10-15 Impact factor: 3.934
Authors: Zhenglun Alan Wei; Phillip M Trusty; Mike Tree; Christopher M Haggerty; Elaine Tang; Mark Fogel; Ajit P Yoganathan Journal: J Biomech Date: 2016-11-10 Impact factor: 2.712
Authors: Elaine Tang; Christopher M Haggerty; Reza H Khiabani; Diane de Zélicourt; Jessica Kanter; Fotis Sotiropoulos; Mark A Fogel; Ajit P Yoganathan Journal: J Biomech Date: 2012-11-30 Impact factor: 2.712
Authors: Christopher M Haggerty; Kirk R Kanter; Maria Restrepo; Diane A de Zélicourt; W James Parks; Jarek Rossignac; Mark A Fogel; Ajit P Yoganathan Journal: J Thorac Cardiovasc Surg Date: 2012-05-04 Impact factor: 5.209